Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00451204
Show Display Options
Rank Status Study
1 Completed
Has Results
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Estriol;   Drug: Placebo;   Drug: Copaxone

Indicates status has not been verified in more than two years